Haemonetics Corp (HAE) income statement
HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 27, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3073% above fair value
$122.86+1.94 (+1.60%)
Close on Nov 18, 2026Market cap $5.59BP/E 59.9Yield –
Haemonetics Corp income statement
Ratios
Latest available, balances at Jun 27, 2026
Profitability, TTM
- Gross margin
- 59.0%
- Operating margin
- 11.9%
- Net margin
- 7.1%
- Return on equity, FY2026
- 12.0%
Financial strength
- Current ratio
- 3.08
- Debt to equity
- 1.40
- Debt to assets
- 49.6%
- Cash to current liabilities
- 84.9%
Valuation
- P/E ratio
- 59.9
- Price to sales
- 4.13
- Price to book
- 6.68
- Dividend yield
- –
See a number that looks wrong?